The milestone moves the company closer to its previously announced $120 million US expansion, with groundbreaking slated for late 2026
Expanding US operations to address the increased demand for API development and manufacturing
SmartTrack aims to reduce the need for clinical studies in generic drug product approvals
Greg was also central to the planning, design, and construction of this facility
Mungara has over 25+ years of experience in the supply chain domain
At commercial scale, Bluestem's patent pending technologies will reduce carbon emission by an estimated 75% or more and be cost-competitive with petroleum based chemicals
The expansion positions Cambrex with the largest and most advanced API facility in the United States
Subscribe To Our Newsletter & Stay Updated
